Disease Activity Progression in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)

被引：0
|
作者：
Morand, Eric [1 ]
Furie, Richard [2 ]
Peschken, Christine [3 ]
Aringer, Martin [4 ]
Arnaud, Laurent [5 ]
Desta, Barnabas [6 ]
Een, Tina Grunfeld [7 ]
Sorrentino, Alessandro [8 ]
Chen, Stephanie [9 ]
Ding, Bo [7 ]
机构：
[1] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, Australia
[2] Northwell Hlth, Manhasset, NY USA
[3] Univ Manitoba, Winnipeg, MB, Canada
[4] Carl Gustav Carus, Dresden, Germany
[5] Univ Hosp Strasbourg, Strasbourg, France
[6] AstraZeneca, BioPharmaceut R&D, Gaithersburg, MD USA
[7] AstraZeneca, BioPharmaceut Med, Gothenburg, Sweden
[8] AstraZeneca, Med Affairs, Cambridge, England
[9] AstraZeneca, BioPharmaceut Med, Gaithersburg, MD USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2263
引用
收藏
页码：4484 / 4486
页数：3
相关论文
共 50 条
  • [1] Organ Damage Progression in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)
    Furie, Richard
    Morand, Eric
    Peschken, Christine
    Aringer, Martin
    Arnaud, Laurent
    Desta, Barnabas
    Een, Tina Grunfeld
    Sorrentino, Alessandro
    Chen, Stephanie
    Ding, Bo
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4552 - 4554
  • [2] Real-World Treatment Patterns in Patients with Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)
    Aringer, Martin
    Arnaud, Laurent
    Furie, Richard A.
    Morand, Eric
    Peschken, Christine
    Desta, Barnabas
    Rapsomaniki, Eleni
    Hedberg, Jonatan
    Een, Tina Grunfeld
    Sorrentino, Alessandro
    Ghia, Canna
    Chen, Stephanie
    Ding, Bo
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1172 - 1174
  • [3] Clinical and Patient-reported Outcomes in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS) US Data
    Furie, Richard
    Binka, Mawuena
    Atefi, Gelareh
    Chen, Stephanie Y.
    Ding, Bo
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4907 - 4909
  • [4] Systemic lupus erythematosus (SLE) disease characteristics associated with the type I interferon gene signature: Baseline data of the SLE prospective observational cohort study (SPOCS)
    Hammond, Edward R.
    Aringer, Martin
    Arnaud, Laurent
    Peschken, Christine
    Knagenhjelm, Jacob
    Barut, Volkan
    Wang, Xia
    Desta, Barnabas
    Tummala, Raj
    Ginkel, David
    Furie, Richard
    Morand, Eric F.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 493 - 493
  • [5] SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE CHARACTERISTICS ASSOCIATED WITH THE TYPE I INTERFERON GENE SIGNATURE: BASELINE DATA OF THE SLE PROSPECTIVE OBSERVATIONAL COHORT STUDY (SPOCS)
    Hammond, Edward R.
    Aringer, Martin
    Arnaud, Laurent
    Peschken, Christine
    Knagenhjelm, Jacob
    Barut, Volkan
    Wang, Xia
    Desta, Barnabas
    Tummala, Raj
    Ginkel, David
    Furie, Richard
    Morand, Eric F.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 139 - 139
  • [6] Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE Prospective Observational Cohort Study (SPOCS) by interferon gene signature
    Arnaud, Laurent
    Furie, Richard
    Morand, Eric F.
    Aringer, Martin
    Peschken, Christine
    Desta, Barnabas
    Rapsomaniki, Eleni
    Hedberg, Jonatan
    Knagenhjelm, Jacob
    Seo, Caroline
    Een, Tina Gruenfeld
    Sorrentino, Alessandro
    Tummala, Raj
    Stirnadel-Farrant, Heide A.
    Ding, Bo
    LUPUS SCIENCE & MEDICINE, 2023, 10 (02):
  • [7] Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)
    Aringer, Martin
    Arnaud, Laurent
    Furie, Richard A.
    Morand, Eric F.
    Peschken, Christine
    Hoi, Alberta
    Desta, Barnabas
    Hedberg, Jonatan
    Een, Tina Grunfeld
    Sorrentino, Alessandro
    Kielar, Danuta
    Tummala, Raj
    Chen, Stephanie
    Ding, Bo
    LUPUS SCIENCE & MEDICINE, 2025, 12 (01):
  • [8] DISCORDANCE BETWEEN PATIENT GLOBAL ASSESSMENT AND PHYSICIAN GLOBAL ASSESSMENT OF DISEASE ACTIVITY IN THE MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS PROSPECTIVE OBSERVATIONAL COHORT STUDY (SPOCS)
    Arnaud, L.
    Furie, R.
    Morand, E. F.
    Peschken, C.
    Aringer, M.
    Rapsomaniki, E.
    Hedberg, J.
    Knagenhjelm, J.
    Seo, C.
    Een, T. Grunfeld
    Desta, B.
    Sorrentino, A.
    Tummala, R.
    Stirnadel-Farrant, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 649 - 650
  • [9] Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature
    Hammond, Edward R.
    Tummala, Raj
    Berglind, Anna
    Syed, Farhat
    Wang, Xia
    Desta, Barnabas
    Nab, Henk
    BMJ OPEN, 2020, 10 (09):
  • [10] HEALTH CARE RESOURCE UTILIZATION (HRU) AND COSTS ASSOCIATED WITH DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A RETROSPECTIVE OBSERVATIONAL COHORT ANALYSIS
    Kan, H.
    Guerin, A.
    Kaminsky, M.
    Yu, A. P.
    Wu, E. Q.
    Denio, A. E.
    Jhingran, P. M.
    Narayanan, S.
    Molta, C. T.
    VALUE IN HEALTH, 2013, 16 (03) : A116 - A116
12345